Table 1. Characteristics of five patients and five controls.
| Variables | HCC (n=25) | HC (n=25) | P-value |
|---|---|---|---|
| Age (years)* | 51.3 ± 10.93 | 52.95 ± 10.23 | 0.31 |
| Gender (women/men) | 6/14 | 6/14 | |
| Platelet count (×109/l)* | 162.3 ± 54.09 | 179 ± 63.3 | 0.18 |
| ALT (U/l)* | 67.9 (27.75, 78.75) | 24 ± 9.33 | P<0.001 |
| Albumin (g/l)* | 50.52 ± 19.75 | 41.75 ± 4.39 | P<0.05 |
| Total bilirubin (μmol/l)* | 25.69 (13.9, 27.28) | 14.7 ± 4.05 | 0.16 |
| AFP (ng/ml) | 2622 (6.99, 2853) | - | |
| Hepatitis B virus infection (%) | 18/20 (90%) | - | |
| Liver cirrhosis (%) | 17/20 (85%) | - | |
| PVTT (%) | 4/20 (20%) | - | |
| BCLC stage (0/A/B/C/D) | 3/9/2/6 | - |
Values are presented as frequency (percent), mean ± standard deviation (SD) or mean (95% CI), where appropriate.
*Difference between HCC group and HC group is calculated by Chi-square test or Student’s t test, where appropriate, and P-value <0.05 is considered statistically significant. Abbreviations: AFP, α fetoprotein; ALT, alanine aminotransferase; BCLC, Barcelona Clinic Liver Cancer; HC, healthy control; PVTT, portal vein tumor thrombus.